3rd Quarter - Report

AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY for AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY

Firm
Client
Income
—
Expenses
$200,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Coalition letter addressed to the Chairman and Ranking Member of the U.S. Committee on Energy and Commerce regarding the need for an independent dispute resolution (IDR) process in any surprise billing legislative solution. Coalition letter addressed to House Energy and Commerce Committee, House Ways and Means Committee, House Education and Labor Committee, and Senate Health, Education, Labor, and Pensions Committee regarding the surprise billing issue and the need for an independent dispute resolution process. Coalition letter addressed to the Administrator of the Centers for Medicare & Medicaid Services regarding agency activities on prior authorization reform, as part of the Patients Over Paperwork initiative. Issues pertaining to health information technology and electronic health records (EHR); in general. Issues pertaining to surprise out of network bills, in general. Issues pertaining to Language Equality and Acquisition for Deaf Kids (LEAD-K) and parent choice; in general. Issues related to hearing healthcare; in general. Federal "Truth in Advertising" Legislation; in general. Issues pertaining to scope of practice; in general. Issues pertaining to Graduate Medical Education; in general.

LobbyistCovered position, as disclosed
MAURA FARRELL —
RUTH ELLEN HAZDOVAC New —
MICHAEL KEEGAN —
KARL MELTON —

Contacted: SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); White House Office; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Coalition letter addressed to the Chairman and Ranking Member of the U.S. Committee on Energy and Commerce regarding the need for an independent dispute resolution (IDR) process in any surprise billing legislative solution. Coalition letter addressed to House Energy and Commerce Committee, House Ways and Means Committee, House Education and Labor Committee, and Senate Health, Education, Labor, and Pensions Committee regarding the surprise billing issue and the need for an independent dispute resolution process. Coalition letter addressed to the Administrator of the Centers for Medicare & Medicaid Services expressing opposition to CMS' proposal to not incorporate the RUC-recommended E/M values into CPT codes with global periods. Coalition letter addressed to the Administrator of the Centers for Medicare & Medicaid Services regarding agency activities on prior authorization reform, as part of the Patients Over Paperwork initiative. Issues pertaining to health information technology and electronic health records; in general. Issues pertaining to surprise out-of-network bills; in general. Issues related to prior authorization, in general. Issues pertaining to the Early Detection and Intervention (EHDI) program, in general. Issues related to hearing healthcare; in general. Issues pertaining to scope of practice; in general.

LobbyistCovered position, as disclosed
MAURA FARRELL —
RUTH ELLEN HAZDOVAC New —
MICHAEL KEEGAN —
KARL MELTON —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; White House Office; Centers For Medicare and Medicaid Services (CMS)

Tobacco TOB

Coalition letter addressed to U.S. Senators expressing opposition to S.9, the Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. Coalition letter addressed to U.S. Representatives expressing opposition to H.R. 1854, the Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. Coalition letter addressed to First Lady Melania Trump regarding the epidemic of youth e-cigarette use in the U.S. Coalition letter addressed to President Donald Trump regarding the epidemic of youth e-cigarette use in the U.S.

LobbyistCovered position, as disclosed
MAURA FARRELL —
RUTH ELLEN HAZDOVAC New —
MICHAEL KEEGAN —
KARL MELTON —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; White House Office

Bills named: H.R. 1854 (116th), S. 9 (116th)

Pharmacy PHA

Coalition letter addressed to the Director of the Food and Drug Administration expressing support for the FDA's efforts to ensure the safety of compounded drug products.

LobbyistCovered position, as disclosed
MAURA FARRELL —
RUTH ELLEN HAZDOVAC New —
MICHAEL KEEGAN —
KARL MELTON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); White House Office

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.